World's Best Scientists 2026 revealed!
Paul G. Richardson

Paul G. Richardson

Award Badge
Best Scientists
2025
Award Badge
Medicine
USA
2026

D-Index & Metrics

Best Scientists

D-Index
225
Citations
236452
World Ranking
112
National Ranking
80

Medicine

D-Index
225
Citations
238635
World Ranking
74
National Ranking
56

Research.com Recognitions

  • 2026 - Research.com Medicine in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in United States Leader Award
  • 2023 - Research.com Medicine in United States Leader Award
  • 2012 - Warren Alpert Foundation Prize For the discovery, preclinical and clinical development of bortezomib to FDA approval and front line therapy for the treatment of patients with multiple myeloma.

Overview

Paul G. Richardson is affiliated with Harvard University in the United States. Their research contributions primarily focus on hematology and oncology, with a significant emphasis on multiple myeloma and related treatments. Over the course of their career, they have published extensively in prominent scientific journals.

Some of their recent papers include:

  • Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial (2020, Blood)
  • Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma (2022, New England Journal of Medicine)
  • Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial (2020, The Lancet)
  • Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group (2021, The Lancet Oncology)
  • Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial (2020, The Lancet Oncology)

Frequent co-authors include:

  • Jacob P. Laubach
  • Meletios Α. Dimopoulos
  • Philippe Moreau
  • Kenneth C. Anderson
  • Omar Nadeem

The scientist's work frequently appears in the following publication venues:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • Synfacts
  • Blood Cancer Journal

The main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields of study cover:

  • Hematology
  • Molecular Biology
  • Oncology
  • Organic Chemistry
  • Genetics

The primary topics of research focus on:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Peptidase Inhibition and Analysis
  • Cancer Treatment and Pharmacology
  • Chronic Lymphocytic Leukemia Research
  • Ubiquitin and proteasome pathways
  • Cancer Mechanisms and Therapy

Among recognitions, Paul G. Richardson received the Warren Alpert Foundation Prize in 2012 for contributions related to the discovery, preclinical and clinical development of bortezomib leading to its FDA approval and use as frontline therapy for multiple myeloma treatment.

Best Publications

  • Initial sequencing and analysis of the human genome.

    Eric S. Lander;Lauren M. Linton;Bruce Birren;Chad Nusbaum

  • The genome of black cottonwood, Populus trichocarpa (Torr. & Gray)

    G. A. Tuskan;G. A. Tuskan;S. DiFazio;S. DiFazio;S. Jansson;J. Bohlmann

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

    S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade

  • A phase 2 study of bortezomib in relapsed, refractory myeloma.

    Paul G. Richardson;Bart Barlogie;James Berenson;Seema Singhal

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

    Paul G. Richardson;Pieter Sonneveld;Michael W. Schuster;David Irwin

  • BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

    Jake E. Delmore;Ghayas C. Issa;Madeleine E. Lemieux;Peter B. Rahl

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • Community structure and metabolism through reconstruction of microbial genomes from the environment

    Gene W. Tyson;Jarrod Chapman;Jarrod Chapman;Philip Hugenholtz;Eric E. Allen

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

    Jesús F. San Miguel;Rudolf Schlag;Nuriet K. Khuageva;Meletios A. Dimopoulos

  • The Genome of the Diatom Thalassiosira Pseudonana: Ecology, Evolution, and Metabolism

    E. Virginia Armbrust;John A. Berges;Chris Bowler;Beverley R. Green

  • The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

    Teru Hideshima;Paul Richardson;Dharminder Chauhan;Vito J. Palombella

  • Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    Antonio Palumbo;Hervé Avet-Loiseau;Stefania Oliva;Henk M. Lokhorst

  • The draft genome of Ciona intestinalis : insights into chordate and vertebrate origins

    Paramvir Dehal;Yutaka Satou;Robert K. Campbell;Jarrod Chapman

  • Whole-Genome Shotgun Assembly and Analysis of the Genome of Fugu rubripes

    Samuel Aparicio;Jarrod Chapman;Elia Stupka;Nik Putnam

  • Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

    Marjon van Slegtenhorst;Ronald de Hoogt;Caroline Hermans;Mark Nellist

  • Comparative genomics of the lactic acid bacteria

    K. Makarova;A. Slesarev;Y. Wolf;A. Sorokin

  • Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

    Meletios A. Dimopoulos;Albert Oriol;Hareth Nahi;Jesus San-Miguel

  • The genome of black cottonwood, Populus trichocarpa (Torr. & Gray) - eScholarship

    G.A. Tuskan;S. DiFazio;S. Jansson;J. Bohlmann

Frequent Co-Authors

Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Nikhil C. Munshi
Nikhil C. Munshi Harvard University
Teru Hideshima
Teru Hideshima Harvard University
Constantine S. Mitsiades
Constantine S. Mitsiades Harvard University
Robert L. Schlossman
Robert L. Schlossman Harvard University
Dharminder Chauhan
Dharminder Chauhan Harvard University
Sagar Lonial
Sagar Lonial Emory University
Noopur Raje
Noopur Raje Harvard University
Yu-Tzu Tai
Yu-Tzu Tai Harvard University
Irene M. Ghobrial
Irene M. Ghobrial Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA can open the door to a wide range of online degrees and healthcare career pathways. For those aiming for advanced clinical expertise, finding the cheapest DNP programs online can help prospective nurse practitioners advance their qualifications affordably.

Pharmacists are also in high demand, and future pharmacists may be interested in exploring pharmacy school online options. These programs offer flexibility and often lower costs, providing an accessible alternative to traditional on-campus study.

If you're still in high school or seeking a supportive transition into healthcare, discovering the best online schools for high school students can give you a head start. These programs often include health information management degrees suitable for future medical professionals.

For those interested in non-clinical roles, taking medical billing and coding classes online offers another promising career pathway. These roles play a critical role in healthcare administration and do not require direct patient care.

Best Scientists Citing Paul G. Richardson

Trending Scientists

Recently Published Articles